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ABSTRACT
Despite their importance for most DNA-templated
processes, the function of individual histone mod-
ifications has remained largely unknown because in
vivo mutational analyses are lacking. The reason for
this is that histone genes are encoded by multigene
families and that tools to simultaneously edit multi-
ple genomic loci with high efficiency are only now be-
coming available. To overcome these challenges, we
have taken advantage of the power of CRISPR–Cas9
for precise genome editing and of the fact that most
DNA repair in the protozoan parasite Trypanosoma
brucei occurs via homologous recombination. By es-
tablishing an episome-based CRISPR–Cas9 system
for T. brucei, we have edited wild type cells without
inserting selectable markers, inserted a GFP tag be-
tween an ORF and its 3′UTR, deleted both alleles of
a gene in a single transfection, and performed pre-
cise editing of genes that exist in multicopy arrays,
replacing histone H4K4 with H4R4 in the absence of
detectable off-target effects. The newly established
genome editing toolbox allows for the generation of
precise mutants without needing to change other re-
gions of the genome, opening up opportunities to
study the role of individual histone modifications,
catalytic sites of enzymes or the regulatory poten-
tial of UTRs in their endogenous environments.
INTRODUCTION
Post-translational modifications (PTMs) of histones, e.g.
acetylation, methylation or phosphorylation, can serve, ei-
ther individually or in combination with other PTMs, as
binding sites for histone binding proteins. Histone bind-
ing proteins, in turn, can induce structural changes in chro-
matin leading to a multitude of biological processes affect-
ing transcription, replication or DNA repair (1). To obtain
insight into the roles of specific PTMs, their distributions
have been mapped throughout diverse eukaryotic genomes,
from trypanosomes to humans, revealing many conserved
features, e.g. an enrichment of histone acetylation at tran-
scription start sites or at sites of double-stranded breaks
(DSB) (2–5). In addition, knowledge of the enzymes respon-
sible for adding or removing specific PTMs is steadily in-
creasing, linking PTMs to specific biological events. How-
ever, while depletion of one of these enzymes may lead to
the loss of a particular histone modification and result in a
specific phenotype, it may also impact other histone mod-
ifications or non-histone proteins complicating the inter-
pretation of such studies. To date, for most PTMs it is not
known whether mutation of a modified histone residue re-
produces the phenotype caused by mutation of the modify-
ing enzyme.
The most direct way to understand the role of specific
PTMs is to replace the histone residue with one that mimics
the modified or unmodified state. While mutational stud-
ies have been used to investigate catalytic sites, structural
domains or binding sites in thousands of proteins, similar
studies are largely missing for histones, with notable excep-
tions in Saccharomyces cerevisiae (6,7) and Drosophila (8).
In yeast, the role of individual histone acetylmarks has been
investigated by replacing the lysine of interest with an argi-
nine or glutamine, to mimic deacetylated and constitutively
acetylated lysine, respectively (7). The primary reason for
the lack of mutational analyses of histones is that they are
encoded by multigene families and that the tools required
to simultaneously edit multiple genomic loci with high ef-
ficiency and without the need for selectable markers, have
not been available. In yeast and Drosophila, these problems
have been circumvented by the concurrent deletion of en-
dogenous histone genes and expression of exogenous mu-
tated histone genes from a plasmid (6,8). While these stud-
ies have yielded valuable information about the role of indi-
vidual PTMs, a substantial advance in understanding their
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function will require manymore such direct loss and gain of
function analyses, spanning evolutionarily highly divergent
organisms.
During the past few years, targeted nucleases have
evolved into powerful tools that allow precise genome ma-
nipulation to be performed at high efficiency in organ-
isms ranging from humans (9) to the protozoan para-
site Plasmodium falciparum (10). Nuclease-induced double-
stranded breaks (DSBs) are generally repaired by error-
prone non-homologous end joining (NHEJ) or, in the pres-
ence of an exogenously introduced repair template, by
the high-fidelity homology-directed repair (HDR) pathway.
While NHEJ-mediated DNA repair typically leads to small
insertions or deletions (INDELs) that can cause frameshift
mutations and the inactivation of a particular gene, the
HDR-pathway can be exploited to introduce specific ge-
nomic alterations. Numerous different targeted nucleases
have been used for genome editing, however, the ease of use
of the RNA-guided endonuclease Cas9 from the microbial
adaptive immune system CRISPR (clustered regularly in-
terspaced short palindromic repeats) makes it particularly
suitable for precise genomemanipulation.When complexed
with CRISPR RNA (crRNA) and a trans activating RNA
(tracrRNA), Cas9 introduces a DSB in a target sequence
that is homologous to the crRNA. The target sequence is re-
ferred to as the protospacer sequence and is located next to
the protospacer adjacentmotif (PAM). To facilitate genome
editing, crRNA and tracrRNA are fused and provided as
a single guide RNA (sgRNA). CRISPR–Cas9 can thus be
used to easily modify virtually any genomic locus as long
as it is in close proximity to a PAM by specifying a 20-nt
targeting sequence within its sgRNA (11). Given that Cas9
has been successfully simultaneously targeted to multiple
genomic loci (12), it should be well suited to precisely edit
multicopy genes such as those encoding histones.
In most organisms the NHEJ pathway is more efficient
than the HDR pathway, which is an obstacle to the pre-
cise editing of multicopy genes. Thus, while Cas9 has been
successfully used to disrupt multicopy genes via repair
through NHEJ, it has not been used for the precise edit-
ing of large multicopy gene arrays. Many protozoa, includ-
ing themedically relevant parasitesTrypanosoma brucei and
Trypanosoma cruzi, the causative agents of sleeping sick-
ness and Chagas disease, have very inefficient NHEJ and
microhomology-mediated pathways (13). For T. brucei it
was observed that in the absence of a repair template the
majority of DSBs will result in cell death rather than repair
by NHEJ or microhomology (14). We have exploited the
absence of efficient NHEJ and microhomology-mediated
pathways inT. brucei to establish a strategy to allow for very
precise genome editing.
The goal of this study was to establish CRISPR–Cas9
technology in T. brucei to allow the study of individual his-
tone modifications. Despite its early divergence from other
eukaryotes, many general patterns of histone PTMs are
conserved in trypanosomes, e.g. just like in most other eu-
karyotes, the N-terminal tail of histone H4 contains several
highly acetylated lysine residues (15).
Here, we describe the development of an episome-based
Cas9 genome editing approach that allows marker-free
genome editing at nucleotide resolution in T. brucei. First,
to establish an efficient genome-editing protocol and to
compare different transfection strategies, we added a C-
terminal GFP tag to theT. brucei homologue of SCD6 (sup-
pressor of clathrin deficiency 6, TbSCD6, Tb927.11.550)
without changing its UTRs. Next, to determine the ro-
bustness of our approach and to exclude the possibility
that only a small set of selected genes can be edited, we
targeted the genes coding for the histone variants H3.V
(Tb927.10.15350) and H4.V (Tb927.2.2670). For these
genes, we were able to delete both alleles in one transfection.
Finally, we evaluated the feasibility of using our episome-
based Cas9 genome editing approach to precisely edit mul-
ticopy genes and succeeded in changing an individual codon
in histone H4. Importantly, and for the first time in T. bru-
cei, all genome edits were performed without the insertion
of a resistance marker.
MATERIALS AND METHODS
Generation of the Cas9-episome and sgRNA-episome(SCD6-
GFP)
Unless mentioned otherwise, all cloning reactions were per-
formed using the In-Fusion HD Cloning Kit (Clontech)
and DNA fragments were amplified using Phusion High-
Fidelity DNA Polymerase (Thermo Scientific) according to
the manufacturer’s instructions. Oligos (Sigma-Adrich) and
synthetic dsDNA fragments (Integrated DNA Technolo-
gies, IDT) are listed in Supplementary Table S1 and an out-
line of the cloning steps can be found in Supplementary Fig-
ure S1. The Cas9- and sgRNA-episomes (Figure 1A) are
based on the pEV Luc episome described previously (16).
To generate the Cas9-episome, the G418 resistance gene
(G418R) was removed from pEV Luc by digestion with SacI
and BamHI and replaced by a puromycin resistance gene
(PURR). To reinsert sequencemotifs required for RNApro-
cessing an In-Fusion reaction was performed with three
fragments: the digested backbone, a DNA fragment to re-
store actin 3′-UTR and the PARP 5′-UTR (amplified with
ocas 1 and ocas 2 from pEV Luc), and the PURR (ampli-
fied with ocas 3 and ocas 4 from pyrFEKO-PUR, Addgene
plasmid #24021), generating pEV Luc puro. Next, to re-
place LUC with hSpCas9 the episome was digested with
KpnI and SacI. To reinsert sequence motifs required for
RNA processing an In-Fusion reaction was performed with
four fragments: the digested plasmid backbone, a DNA
fragment to the 5′-UTR of the actin gene (amplified with
ocas 5 and ocas 6 from pEV Luc puro), Cas9 and a DNA
fragment to restore the actin 3′-UTR (amplified with ocas 7
and ocas 8 from pEV Luc puro).
To add an HA-tag and an SV40 NLS to hSpCas9 CDS,
theCas9CDSwas amplified frompX330 (Addgene plasmid
#42230, (17)) using the oligo pair ocas 9/10 from pX330,
and ligated into pRPa (18) after both fragments were di-
gested with HindIII and BamHI, yielding pCW20. Next,
the tagged Cas9 was excised from pCW20 by digestion with
SbfI and AflII and used in the above-mentioned In-Fusion
reaction to generate the Cas9-episome (Figure 1A).
To generate the sgRNA-episome, the LUC locus and a
part of the G418 resistance gene were removed from the
pEV Luc episome by digestion with KpnI and NcoI. Next,
the primer pair ocas 11/12 was used to amplify the PARP
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5´UTR 3´UTRSCD6
eGFPrepair sequence
hSpCas9NLSHA
Cas9-episome
PURR
sgRNA-episome(SCD6-GFP)
G418R
repairHDVHH crRNA tracrRNA
crRNA
SbfI SacI NheI
HpaIBamHI
5´...CGTGGGGGCCGGGGACGTTACAACGGCCGCTACA
ACTAAtaaaggcgtccggtgcggagttgcgaaataacc
gcttagggaaatatgt...3´
3´...GCACCCCCGGCCCCTGCAATGTTGCCGGCGATGT
TGATTatttccgcaggccacgcctcaacgctttattgg
cgaatccctttataca...5´
crRNA1
Figure 1. Strategy for episome-based Cas9 genome editing. (A) Key features of the Cas9- and the sgRNA-episome. Black arrow: PARP (procyclic acidic
repetitive protein) promoter; HA: HA-epitope; NLS: SV40 nuclear localization signal; hSpCas9: human codon-optimized Cas9; PURR: puromycin N-
acetyl transferase CDS conferring resistance to puromycin; G418R: neomycin phosphotransferase conferring resistance to G418; HH: hammerhead ri-
bozyme; crRNA: CRISPR-RNA; tracrRNA: trans activating RNA; HDV: hepatitis delta virus ribozyme; repair: sequence providing the DNA repair
template carrying the desired mutations. (B) Sequence of the genomic target on Chr 11, 140,068-140,155. SCD6 ORF: black, uppercase; SCD6 3′ UTR:
black, lower case; protospacer: purple highlight; PAM: green. (C) Strategy for the marker-free tagging of the SCD6ORF. The purple triangle indicates the
protospacer location targeted by the crRNA (not drawn to scale). The repair template encompasses the eGFP ORF flanked by 220 bp of the 3′-end of the
SCD6 ORF and 220 bp of its 3′-UTR.
5′-UTR and the previously removed fragment of the G418
CDS from pEV Luc. The PCR product was inserted using
the In-Fusion Kit generating pEV-noLuc. Subsequently, to
permit insertion of a repair sequence, an SbfI restriction
site was introduced downstream of the resistance marker
gene by site-directed mutagenesis. To this end, two frag-
ments were amplified from pEV Luc using ocas 13/14 and
ocas 15/16 and fused via PCR using ocas 13/16. Both the
fusion PCR product and pEV-noLuc were digested with
BamHI and NheI and joined by ligation to generate the
sgRNA-episome. The repair sequence containing the 3′-end
(220 bp) of the SCD6CDS (Tb927.11.550), the eGFPCDS,
and the 3′-UTR (220 bp) of SCD6 was synthesized in two
fragments (gcas 1, gcas 2) and inserted into the sgRNA-
episome after SbfI and NheI digestion. Following diges-
tion of the sgRNA-episome with SbfI and SacI, the sgRNA
flanked by ribozymes (gcas 3) was inserted to generate the
sgRNA-episome(SCD6-GFP.1) (Figure 1A).
Construction of sgRNA-episomes to generate ΔH4.V,
ΔH3.V and H4R4 cell lines
To generate the ΔH3.V, ΔH4.V and H4R4 cell lines, the
sgRNA-episome(SCD6-GFP.1) was digested with SacI and
NheI and the respective repair sequences (see below) were
inserted. Next, the episomes were digested with SbfI and
SacI and the corresponding sgRNA sequences (gcas 6,
gcas 7, gcas 8, Supplementary Table S1) were inserted. Pro-
tospacer sequences were chosen to target Cas9 as closely as
possible to the start codon of histone H4.V, H3.V or H4.
To disrupt H3.V the repair sequence was generated such
that it included only the first 27 nt and the last 29 nt of the
H3.V CDS. The upstream and downstream regions of the
repair sequence were amplified from gDNA using the oligo
pairs ocas 17/18 and ocas 19/20, respectively. To obtain the
complete repair sequence, a fusion PCR of both fragments
using the oligos ocas 21 and ocas 20 was performed. The
PCR product was inserted into the backbone to yield the
sgRNA-episome(H3.V).
To delete H4.V the repair sequence was designed such
that it did not include any nucleotide of the H4.V CDS
and was amplified with the oligo pair ocas 22/23 from a
syntheticDNA fragment (gcas 9, Supplementary Table S1).
The PCR product was inserted into the backbone to yield
the sgRNA-episome(H4.V).
To generate the H4R4 cell line a repair sequence con-
taining an arginine codon (CGC) instead of a lysine codon
(AAG) in the fifth triplet position of theH4CDSwas ampli-
fied with the oligo pair ocas 24/25 from a synthetic DNA
fragment (gcas 10, Supplementary Table S1). In addition,
the repair sequence contained a silent mutation (AGG to
AAG) in the PAM sequence.
A step-by-step instruction on how to edit a specific gene
can be found in the supplementary material.
Construction of sgRNA-episome(G418R)
The G418 resistance gene from sgRNA-episome(H4.V)
was removed by digestion with HpaI and BamHI and re-
placed by a hygromycin resistance gene, which was am-
plified with ocas 26 and ocas 27 from pLEW100v5 HYG
(kind gift from George Cross, Addgene plasmid #24012).
After digestion with SbfI and SacI a sgRNA sequence to
target the neomycin resistance gene was inserted (gcas 11
and gcas 12, Supplementary Table S1).
Co-transfection of T. brucei Lister 427 procyclic form with
episomes
Transfections of T. brucei Lister 427 procyclic forms
were performed using a Nucleofector (Amaxa) as de-
scribed previously (19). For the transfection 10 g of both
the Cas9-episome and sgRNA-episome(SCD6-GFP.1/2/3)
were added to a cold cuvette (VWR 2mm, 400l), followed
by the addition of 2× 107 cells suspended in 400l of trans-
fection buffer (20). Immediately after transfection the cells
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were suspended in 5 ml of SDM79 medium (21) (contain-
ing 20% fetal calf serum, FCS) and incubated overnight at
27◦C. The next day, puromycin and G418 were added to the
culture to a final concentration of 1 and 15 g/ml, respec-
tively. The drug selection was removed 5 days post transfec-
tion and fluorescence was determined by microscopy.
Sequential transfection of T. brucei Lister 427 procyclic form
with episomes
Sequential transfections were performed following the pro-
tocol described for the co-transfection except for the fol-
lowing changes: following transfection the cells were sus-
pended in 10 ml of SDM79 medium (containing 20% FCS)
and split between two flasks. The next day, puromycin was
added to the flasks to a final concentration of 1 g/ml.
The cells that survived the selection process were transfected
with the sgRNA-episomes containing the sgRNA and re-
pair sequences for the SCD6-GFP tagging,H4.V andH3.V
deletion or H4R4 substitution following the procedure de-
scribed above. The next day, G418 was added to a final con-
centration of 15 g/ml. After 10 days the cultures were seri-
ally diluted using SDM79 (containing 20% FCS and drugs)
to 1:1 × 101, 1:1 × 102, 1:1 × 103, 1:1 × 104, 1:1 × 105 and
1:1 × 106 and transferred to 96-well plates, 200 l per well.
Monitoring of GFP-positive cells
Live microscopy was performed using an EVOS® FL
Imaging System (Thermo Scientific) equipped with a Sony
ICX285AQ color CCD camera and a LED light cube suit-
able for the detection ofGFP. The cells were observed under
both bright field and fluorescence using a 20× objective. In
the serially diluted cultures each well was evaluated for the
presence or absence of fluorescent cells. A well was consid-
ered to contain GFP-positive cells only if the majority of
cells were fluorescent.
Evaluation of GFP-positive cells using flow cytometry
AMACSquant analyzer 10 (Miltenyi Biotec) equippedwith
a laser excitation of 488 nm coupled with 530/30 and 505LP
sequential filter was used to evaluate the presence of GFP-
positive cells. The photomultiplier voltage was set at 388 V
and 100 000 events were measured for 7 samples transfected
with the Cas9- and the sgRNA-episomes.
Fluorescence microscopy
Microscopy images were taken on a Leica DMI6000B mi-
croscope equipped with a Leica CRT6000 illumination sys-
tem and a color camera LeicaDFC630FX. The images were
taken with a HCX PL APO oil immersion objective with
100 × 1.47 magnification or with a HCX PL FLUOTAR
dry objective with 40 × 0.6 magnification. Linear image
processing was done using LeicaApplication Suite Advance
Fluorescence Software. TheDAPI signal was detected using
an excitation filter 359 nm and emission filter 461 nm (ex-
citation filter BP 360/40 and suppression filter BP 470/40).
The eGFP fluorescence signal was detected using an excita-
tion filter 489 nm and an emission filter 508 nm (excitation
filter BP 480/40 and suppression filter BP 527/30). Seven
clones transfected with the Cas9- and the sgRNA-episomes
were analyzed by counting ∼ 100 cells per clone, estimat-
ing the number of fluorescent cells over the total number of
cells.
Southern blotting
Probes were designed to target the SpCas9 CDS (nu-
cleotides 1136–1715). -tubulin was used as a positive con-
trol for genomic DNA (nucleotides 967–1088). The probes
were synthesized by performing PCRs using the primers
ocas 28 and ocas 29 for the SpCas9 probe, and the primers
ocas 30 and ocas 31 for the β-tubulin probe.
PCR reactions were performed using the Phusion High-
Fidelity DNA Polymerase as described by the manufac-
turer (Thermo Scientific). The PCR products were run on a
1% agarose gel and the corresponding bands excised from
the gel and cleaned up. The probes were labeled with [-
32 P]dATP using the DECAprime II Procedure following
the manufacturer’s instructions (DECAprime™ II Kit Am-
bion).
For the Southern blotting, genomic DNA was extracted
using DNAzol® (Thermo Scientific) from cells sequen-
tially transfected with the Cas9- and the sgRNA-episomes
that were kept for 10 days in a flask before transfer to 96-
well plates. The drug pressure was removed onemonth prior
to harvest. 30 g of each gDNA sample were digested with
200 U of KpnI overnight at 37◦C while shaking at 80 rpm.
The next day, 100 U of KpnI were added and the reaction
was incubated for four additional hours to ensure complete
digestion. TheDNAwas precipitated and resuspended in 50
l of water. In parallel, 30 g of the Cas9-episome were di-
gested with 40U of KpnI and precipitated. The digestion of
this episome allowed us to have a hybridization control for
the Cas9 probe and to perform a semi-quantitative South-
ern blot by loading different concentrations.
The digested gDNA of wild type cells and sequentially
transfected parasites corresponding to 150 million cells
were loaded onto a 0.7% agarose gel and run at 30 V
overnight. Assuming one cell contained on average one of
each episome (22), digested Cas9-episome equivalent to 150
× 104, 150 × 105 and 150 × 106 molecules were loaded to
allow quantification of the episome integration frequency.
The DNA transfer and hybridization steps were performed
according to the Hybond-XL instruction manual (Amer-
shamBiosciences) and (23). Briefly, the membranes were in-
cubated for two hours at 68◦C in 50 ml of 1× prehybridiza-
tion solution (5× SSC, 5× Denhardt’s solution, 0.5% (w/v)
SDS, 10 g/ml herring sperm) using glass cylinders in a hy-
bridization oven while rotating. The probes were prepared
by resuspending 12.5l of them in 100 l of water, denatur-
ing by heating for 10 min at 100◦C and chilling immediately
on ice for 2 min. The denatured radiolabeled probes were
added directly to the prehybridization solution. The incu-
bation was continued for 12–16 hours at 68◦C. After hy-
bridization the membranes were transferred as quickly as
possible to another cylinder containing 50 ml of 2× SSC,
0.5% SDS and washed for 5 min at room temperature. Af-
ter 5 min, the first rinse solution was poured off and 50 ml
of 2× SSC, 0.1% SDS were added to the cylinders and the
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membranes were incubated for 15min at room temperature.
The rinse solution was replaced with 50 ml of fresh 0.1×
SSC, 0.1% SDS and the membranes were incubated for 2
h at 65◦C. Then, they were briefly washed with 0.1× SSC
at room temperature, dried on blotting paper, and wrapped
in plastic foil. The membranes were finally introduced in a
cassette with a phosphor imager screen for 1 h. The screen
was scanned in a Thyphoon fla7000 (GE Healthcare Life
Sciences).
Monitoring of genome editing by PCR and Sanger sequenc-
ing
To monitor the genome editing in SCD6-GFP, ΔH3.V and
ΔH4.V cell lines, gDNA from multiple transfected clones
andwild type PF cells was extracted from 1× 106 cells using
the Phusion Human Specimen Direct PCR kit (Finnzymes)
according to the manufacturer’s instruction. Primer se-
quences are listed in Supplementary Table S1. To detect
SCD6-GFP positive cells the oligos ocas 32/33 were used.
For the endogenous allele an amplicon size of 1466 bp and
for the SCD6-GFP allele an amplicon size of 2186 bp is ex-
pected. To detect ΔH3.V cells the oligos ocas 34/35 were
used. For the endogenous allele an amplicon size of 1572
bp and for the ΔH3.V allele an amplicon size of 1208 bp is
expected. To detect ΔH4.V cells the oligos ocas 36/37 were
used. For the endogenous allele an amplicon size of 1174 bp
and for the ΔH4.V allele an amplicon size of 871 bp is ex-
pected. To determine the presence of H4R4 editing events,
gDNA was extracted as described above and amplified us-
ing the oligos ocas 38/39 (Supplementary Figure S2). The
smallest PCR product from each reaction was excised and
analyzed by Sanger sequencing. Analyses were repeated at
multiple time points.
Whole genome sequencing
The DNeasy Blood and Tissue Kit (Qiagen) was used to
extract DNA from wild type and Cas9-edited cells. Six mi-
crogram of DNA was suspended in 100 l of TE buffer (10
mMTris–HCl, 1mMEDTA, pH 8.0) and fragmented using
a Bioruptor Plus (Diagenode) at the following settings: low-
power, 70 cycles of 30 s ‘on’ followed by 30 s ‘off’. Next, frag-
ments between 100 and 300 bpwere size-selected by gel elec-
trophoresis and 40 ng were used to prepare indexed DNA
libraries as described previously for DNA fromChIP assays
(24). After purification, fragment sizes and library quality
were analyzed in a Bioanalyzer 2100 (Agilent) and theDNA
concentration was determined in a Qubit Fluorometer (Life
Technologies). Finally, the libraries were sequenced using
the NextSeq 500/550 v2 Kit and a NextSeq500 sequencer
(Illumina).
Off-target analysis
To identify off-target cleavage by Cas9 we followed a pre-
viously published strategy (10,25). Paired-end reads from
wild type, SCD6-GFP and H4R4 (clone B3-3-1) cells were
mapped to the T. brucei Lister 427 genome version 26,
downloaded from TriTrypDB database, using bwa (https://
arxiv.org/abs/1303.3997), version 0.7.12-r1039. Sorted bam
files were obtained using samtools ((26), version 1.5).
VarScan (v2.4.3) software (27) was used to detect INDELs
and extract specific INDELs from the edited cell lines by
comparing them to the wild type cell line. The command
mpileup2indel was used to call INDELs using default op-
tions, with the exception of the P-value threshold for call-
ing variants, which was set to 0.05 instead of 0.01. Then,
the specific INDELs occurring in the edited cell lines were
extracted using the ‘compare’ command of VarScan.
The ProtospacerWorkbench software suite (28) was used
to find putative off-targets from the original seeds, ‘AGCG
GCCGTTGTAACGTCCC’ corresponding to the sgRNA1
targeting SCD6, and ‘GAAGGGTAAGAAGAGTGGTG’
corresponding to the sgRNA1 targeting H4. The off-target
candidates where identified using the third-party software
RazersS3 (29) allowing up to five mismatches, and ranked
by the score given by the algorithm developed previously
(11). For all off-target candidates, the vicinity (within a 21-
nt window) to specific INDELs of the edited cell lines was
assessed. The ranked lists of off-targets for the assessed sgR-
NAs are available in the Supplementary Table S2. In wild-
type, SCD6-GFP and H4R4 cells we identified 6216, 4342,
9254 (P < 0.05) INDELs, respectively (Supplementary Ta-
ble S3). The higher amount of INDELs in the H4R4 cells
compared to wild type cells may be partially attributed to
the sequencing depth. Wild type cells were sequenced to
21.3x coverage, whereasH4R4 cells were sequenced to 29.5x
coverage. As we sequence deeper, more INDELs become
significant.
Estimation of histone H4 gene array length and number of
episomes per cells
Sequence reads from wild type, SCD6-GFP and histone
H4R4 (clone B3-3-1) cells mapping to histone H4 genes in
the T. brucei Lister 427 genome version 26 were counted
with bedtools (30), v2.26.0 using the ‘multicov’ com-
mand, normalized to counts per kilobase and added up.
Counts per kilobase were also calculated for four other
single-copy genes: (i) H2A.Z (Tb427.07.6360), (ii) RPB9
(Tb427tmp.02.5180), (iii) PPL1 (Tb427.05.4070) and iv)
XNRE (Tb427.05.3850), and the average was used as the ex-
pected counts per kilobase for a single-copy gene. The ratio
between the added-up counts per kilobase of readsmapping
theH4 genes and the average counts per kilobase of the se-
lected single-copy genes was used as an estimation of the
histone H4 gene array length.
The same approach was used to calculate the number of
episomal copies per cell except that the reads were mapped
to a hybrid genome composed of the T. brucei Lister 427
genome version 26 and the Cas9-episome, and the reads
mapping to Cas9 were counted instead of those mapping
to histone H4.
Analysis of episome integration
To determine if episomes had integrated into the genome,
we mapped the paired-end DNA-reads from wild type,
SCD6-GFP and H4R4 cells to the episome-Cas9 and the
T. brucei genome, as described above. Next, we inspected
read-pairs of which one read mapped to the episome and
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one to the genome. The number of reads fulfilling these cri-
teria was extremely small for all three cell lines and no ev-
idence was detected suggesting episome integration in the
cells transfected with the Cas9-episome (data not shown).
RESULTS
Establishment of an episome-based CRISPR–Cas9 system in
T. brucei
To enable genome manipulations in wild type cells, Cas9
and sgRNAswere expressed from episomes. Episome-based
expression of Cas9 has been reported for other protozoan
parasites (10,25,31). Given the large size (>10 kb) of avail-
able episomes (22), we established a two-episome system:
one episome expressing human codon-optimized Strepto-
coccus pyogenes Cas9 containing an HA-epitope tag and
an N-terminal SV40 nuclear localization signal and a sec-
ond episome coding for the desired sgRNA and carrying a
donor DNA repair template to ensure efficient and precise
DNA repair via the HDR pathway (Figure 1A).
In most CRISPR–Cas9 applications, including studies
published for Plasmodium falciparum (10) and Leishma-
nia major (25), RNA polymerase III promoters (e.g. U6
promoters) have been used to transcribe the sgRNA. The
U6 promoter structure found in most organisms allows the
transcription of sgRNAswith precise 5′- and 3′-ends, avoid-
ing the incorporation of additional nucleotides that could
interferewith normal sgRNA function.However, theT. bru-
ceiU6 promoter contains an essential element inside the U6
gene, making it unsuitable for the transcription of sgRNAs
(32). In addition to U6 promoters, T7 promoters have been
used to drive in vivo sgRNA transcription (33,34) and are
widely used to overexpress genes in T. brucei (35). How-
ever, reliance on T7 polymerase restricts the use of Cas9-
based editing to transgenic cell lines expressing T7 poly-
merase. Thus, to edit wild type trypanosomes, we employed
the endogenous PARP (procyclic acidic repetitive protein)
promoter to transcribe the sgRNA. To ensure its correct
length, the sgRNAwas flanked by a hammerhead ribozyme
at its 5′-end and a hepatitis delta virus ribozyme at the 3′-
end (36).
To facilitate the establishment of an efficient Cas9-based
genome editing protocol in T. brucei, we tagged the T. bru-
cei homologue of SCD6 with eGFP. Expression of a GFP
tag provided a rapid means to assess the efficiency of dif-
ferent transfection strategies; furthermore, SCD6 is highly
expressed in T. brucei (37) and tolerates a fluorescent pro-
tein tag at its 3′-terminus (38).
To insert the eGFP ORF between the SCD6 ORF and
its 3′-UTR, a sgRNA was designed to guide Cas9 to intro-
duce a DSB at the 3′-end of the SCD6 ORF (Figure 1B).
Downstream of the sgRNA, the episome contained a repair
sequence encompassing the eGFP ORF (Figure 1C).
Cas9 allows genome editing at high efficiency
To establish transfection conditions, we first compared the
co-transfection of the ‘Cas9-episome’ and the ‘sgRNA-
episome(SCD6-GFP.1)’ to the sequential transfection of
both episomes. While co-transfections yielded several green
fluorescent cells (Figure 2A), sequential transfections re-
sulted in a much higher percentage of GFP-positive cells
(Figure 2B). No green fluorescent cells were obtained af-
ter transfection of a control episome lacking a sgRNA se-
quence (Figure 3A). As reported previously, the episomes
were stably maintained for more than 2 months (22), even
aftermultiple cycles of freezing and thawing. Thus, cells car-
rying the Cas9-episome can be used as a starting cell line for
different genetic manipulations.
Next, we optimized the sequential transfection approach.
Cells carrying the Cas9-episome were transfected with the
sgRNA-episome(SCD6-GFP.1), diluted and transferred to
96-well plates either immediately or 10 days post transfec-
tion (Figure 2B). Immediate dilution and transfer has the
advantage that edited cells with a growth phenotype will
not be outgrown by wild type cells in which editing did
not occur. However, if the editing takes place after dilution
and transfer, this will result in a heterogenous population
of cells. Heterogeneity may occur at the population level,
with editing occurring in some cells and not others, or at
the genome level, with some cells carrying homozygous and
others carrying heterozygous genomic changes. Thus, late
dilution and transfer should increase the homogeneity of a
particular clone.
To assess the effect of immediate versus delayed dilution
and transfer on homogeneity, we determined the number of
GFP-positive and GFP-negative clones for cells that were
immediately diluted and transferred and those that were di-
luted and transferred after 10 days. Delayed dilution and
transfer resulted in ∼90% of clones being edited compared
to ∼10% after immediate dilution and transfer (Table 1).
To further characterize the SCD6-GFP.1 clones (diluted
and transferred after 10 days), we employed fluorescence
microscopy, FACS, PCR and Sanger sequencing. Both
FACS and imaging (Figure 3A-B and Supplementary Fig-
ure S3) of cells from GFP-positive wells indicated that all
clones initially classified as GFP-positive contained more
than 90% of GFP-positive cells. Thus, Cas9 can be used to
perform marker-free genome editing in T. brucei with high
efficiency.
To assess whether both or just one allele contained aGFP
tag, gDNA from several clones was analyzed by PCR. We
found a mixture of both outcomes; some clones were ho-
mozygous for the SCD6-GFP gene while others were het-
erozygous (Figure 3C). To understand why only one allele
was edited in the heterozygous clones, we sequenced the
smaller of the two PCR products, assuming it represented
thewild type allele, and foundmutations in the PAMor pro-
tospacer sequence (Figure 3D). YFP tagging of SCD6 has
been reported to lead to a growth defect (37). Thus, while
tagging of both alleles in one transfection is possible, our
data suggest that if editing events lead to a growth defect,
there may be selection for compensatory mutations, such as
mutations in the PAMor protospacer sequence that prevent
editing.
Cas9-mediated editing leads to negligible off-target effects
The specificity of Cas9 is determined by the 20-nt sequence
of the crRNA and the PAM (NGG for SpCas9). However,
although the length of the target sequence should be suf-
ficient to ensure targeted cleavage even in large genomes
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Figure 2. Outline of transfection strategies. (A) Co-transfection strategy. (B) Sequential transfection strategy.
(∼3Gb), numerous studies have reported that Cas9 can in-
duce off-target mutations, even at sequences that differ by
5 nt from the targeted site (11,39,40). Given the absence of
an NHEJ pathway in T. brucei (13) and findings using the
meganuclease I-SceI in T. brucei (14), we expect that cleav-
age at off-target sites, for which no repair template is pro-
vided, will not be repaired efficiently and will result in cell
death rather than in unintended editing events. Neverthe-
less, to assess the degree of off-target mutations in T. brucei,
we sequenced gDNA from wild type cells and a population
of cells edited using the sgRNA-episome(SCD6-GFP.1) to
21.3x and 22.9x coverage, respectively. Typically, off-target
editing results in small INDELs. Thus, we searched the
genome of the edited cells for the presence of INDELs in the
vicinity of potential off-target sites that differ by≤5 nt from
the target site as described previously (10,25). Potential off-
target sites were identified using the software RazersS3 (29),
which is part of the ProtospacerWorkbench (28), for details
seemethods.However, no INDELswere identified at poten-
tial off-target sites, indicating that off-target editing events
are negligible in T. brucei (Supplementary Table S2). DNA
sequencing also confirmed original reports of ∼1 episome
per cell (Supplementary Figure S4).
Cas9 allows multiple genome edits in parallel or in sequence
To increase the versatility of Cas9-mediated editing, we
tested strategies to edit multiple genomic loci, e.g. to allow
deletion of multiple genes.
The episome used in this study has been reported to be
highly stable and not to integrate into the genome (22). Our
study confirmed these observations. We found cells to re-
main resistant to G418 even when they had been cultured
for 2 months without drug pressure, suggesting that the
episome had been efficiently maintained. To evaluate the
frequency of episome integration, we performed Southern
blotting using DNA from a population of cells edited with
the sgRNA-episome(SCD6-GFP.1) and found no evidence
for integration (Supplementary Figure S4A). Analysis of
gDNA-seq data from the same population suggested the
presence of∼1.1–1.5 episomes per cell (Supplementary Fig-
ure S4B) as published previously (22) and yielded no indi-
cation that episome integration had taken place. Next, to
investigate whether episomes could be actively removed, for
example once editing had occurred, we decided to generate
a second sgRNA-episome expressing a sgRNA recruiting
Cas9 to cut the first sgRNA-episome at the neomycin re-
sistance gene. In the absence of a repair template the cut
should not be repaired and the episome should be lost (Fig-
ure 4A).
To test this approach, we first generated sgRNA-
episomes to permit deletion of the histone variants H3.V
orH4.V. Deletion ofH3.V andH4.V occurred in both alle-
les in 100% and 66% of the clones, respectively (Figure 4B).
Sanger sequencing of PCR products from threeΔH3.V and
three ΔH4.V clones confirmed that the edited regions ex-
actly matched the provided DNA repair template (Figure
4C). Thus, for genes that can be deleted without inducing a
growth defect, both alleles were efficiently edited in a single
transfection.
In a second step, to perform additional genome edits,
we replaced the resistance marker G418R of the sgRNA-
episome with a hygromycin resistance gene (HygR). In addi-
tion, we inserted a sgRNA targeting theG418R gene present
in the sgRNA-episome used to delete H3.V during the first
round of genome editing. As expected because the newly
constructed sgRNA-episome lacked a template sequence to
facilitate repair of the G418R gene (Figure 4A), cells trans-
fected with sgRNA(G418R) regained sensitivity to G418
treatment, indicating a loss of the first sgRNA-episome car-
rying the G418R gene. Thus, the efficient removal of epi-
somes can allow multiple editing events.
Cas9 can be used to change single residues in multicopy his-
tone arrays
The goal of this study was to determine whether CRISPR–
Cas9 technology could be used to study the role of individ-
ual histone residues. As a proof of principle, we replaced
the lysine at position 4 on histone H4 (H4K4) with an
arginine (H4R4) to mimic the constitutively non-acetylated
state (Figure 5A). In wild type T. bruceiH4K4 is acetylated
in 80% of the histones (15) and in cells lacking the histone
acetyltransferase 3 (ΔHAT3 cells) H4K4ac levels drop to
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Figure 3. Cas9 allows marker-free genome editing at high efficiency. Unless indicated otherwise, cells were sequentially transfected with the Cas9-episome
and the sgRNA-episome(SCD6-GFP.1) and diluted 10 days after transfection. Cells were only analyzed if <20 wells per 96-well plate contained living
cells. (A) Fluorescence microscopy analysis of cells transfected with sgRNA-episome(SCD6-GFP.1, clone B4) or a sgRNA-episome lacking a sgRNA (-
crRNA). (B) Flow cytometry analysis of edited cells. Left panel: wild type cells (gray) and cells in which SCD6 was GFP-tagged using the pMOT system
(55) (green). Right panel: wild type cells (gray) and a representative clone of cells transfected with the sgRNA-episome(SCD6-GFP.1, clone B4). (C) PCR-
based analysis of wild type cells, six clones of cells transfected with sgRNA-episome(SCD6-GFP.1) and cells transfected with an sgRNA-episome lacking a
sgRNA (-crRNA). Top panel: outline indicating primer binding sites (half arrows). Bottom panel: agarose gel revealing the presence of homozygous (one
PCR product) or heterozygous (two PCR products) tagging events. (D) Sanger-sequencing results of the SCD6 gene from wild type cells, the non-edited
SCD6 allele of three heterozygous clones and cells transfected with a sgRNA-episome lacking a sgRNA (-crRNA).
5–10% with no growth defect (41,42). Based on the analysis
of deep sequencing data of gDNA, we estimated the num-
ber of histone H4 genes to be ∼43 (21.5 per homologous
chromosome).
Since we suspected that editing is a dynamic process that
proceeds over weeks, we designed one sgRNA to target the
multicopy histone H4 array (Figure 5B) and monitored the
replacement of H4K4 with H4R4 over a period of 5 months
(Figure 5C).
The first copies of histone H4R4 were detected after 3
months in one out of three analyzed clones (Figure 5C).
To obtain clonal populations, cells were diluted again and
transferred to a new 96-well plate. Analysis of the subclones
revealed a strong increase in the percentage of H4R4 (Fig-
ure 5C). Deep sequencing of the gDNA from the Cas9-
edited cells indicated that∼90% ofH4K4was replaced with
H4R4 (Figure 5C). At 29x coverage genome sequencing, no
INDELs were detected in the vicinity of putative off-target
sites (Supplementary Table S2) and we found the number of
H4 copies to drop from ∼43 to ∼26 (Figure 5D). Thus, in
the absence of an efficient NHEJ pathway Cas9 technology
can be used for the precise editing of histone gene arrays.
DISCUSSION
The availability of versatile and reliable genetic tools is one
of the key reasons whyT. brucei has become one of the most
importantmodel protozoa. For a long time, it has been rela-
tively easy to generate knockout T. brucei parasites, to over-
express specific genes and to exploit the endogenous RNAi
pathway to deplete transcripts.
The goal of this study was to further extend the avail-
able toolbox and to exploit the absence of efficient NHEJ
to develop a strategy to study individual histone modifi-
cations. The approach presented here enables, for the first
time, genome editing in T. brucei without the need to insert
a selectable marker, editing of individual nucleotides and of
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Table 1. Comparison of immediate versus delayed dilution and transfer
Immediate dilution and transfer Delayed dilution and transfer (10 dpt)
Dilution
Wells with living
parasites
Wells with
GFP-positive
parasites*
% of wells with
GFP-positive
parasites
Wells with living
parasites
Wells with
GFP-positive
parasites*
% of wells with
GFP-positive
parasites
1:10 41 5 12 96 ND ND
1:100 7 0 0 96 ND ND
1:1000 0 0 0 84 75 89
1:10 000 0 0 0 51 45 88
1:100 000 0 0 0 18 17 84
1:1 000 000 0 0 0 19 17 89
*Wells were classified as GFP-positive if the majority of cells appeared to express GFP. Analysis was performed using an EVOS FL imaging system
(Invitrogen). Note, the numbers listed in this table are derived from the original protocol optimization. The numbers of wells with living parasites obtained
at the different dilutions varied strongly among transfections.
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TGA
CGACCGGTGAGACCCAAAAGTGTTGCCTCTCGCCCAATACAAGCGGTGGCACGCGCTCCC
GTCAAAAAAGTCGAAAATACACCTCCGCAAAAACGCCACCACCGCTGGCGCCCGGGAACC
GTCGCCCTGCGCGAAATTCGGCGGTTGCAAAGTTCCACCGATTTTCTCATCCAACGGGCG
CCCTTCCGCCGTTTTTTACGAGAGGTGGTGTCAAACTTGAAGGATTCCTACCGCATGAGT
GCGGCATGTGTCGATGCTATTCAGGAAGCAACTGAAACATATATTACATCTGTATTTATG
GATGCAAATCTCTGTACGTTGCATGCTAATCGTGTTACTCTGTTCCCAAAGGATATCCAA
TTGG
deleted
sequence
repair templateTTCATGGCGCAAATGAAGAAAATAACACCGCGCTTAAACTCCGAGGCGAGCGTAACTAAA
TTCATGGCGCAAATGAAGAAAATAACACCGCGCTTAAACTCCGAGGCGAGCGTAACTAAA
TTCATGGCGCAAATGAAGAAAATAACACCGCGCTTAAACTCCGAGGCGAGCGTAACTAAA
TTCATGGCGCAAATGAAGAAAATAACACCGCGCTTAAACTCCGAGGCGAGCGTAACTAAA
C
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Figure 4. Cas9 allows multiple genome edits. (A) Strategy used for the removal of the sgRNA-episome. (B) PCR-based analysis of cells sequentially
transfected with the Cas9-episome and sgRNA-episome(H3.V) or sgRNA-episome(H4.V). Top panel: outline indicating primer binding sites (half
arrows). Bottom panel: agarose gel revealing presence or absence of H3.V (left) or H4.V (right). Homozygous deletions of H4.V were only observed after
the culture had been diluted a second time. (C) Sanger sequencing demonstrated that all editing events exactly matched the repair template. The deleted
CDSs of H3.V and H4.V are represented on top and highlighted in orange. The repair templates are shown in the middle (5′-UTR in green, 5′-end of the
H3.V CDS in orange and 3′-UTR in purple. The sequencing chromatograms are depicted at the bottom.
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Figure 5. Cas9 allows editing of multicopy histone arrays. (A) Structure of acetylated lysine and arginine. (B) Sequences of the crRNA(H4R4) and the
relevant regions of the H4R4 repair template. (C) Sanger-sequencing chromatograms from gDNA of cells transfected with the sgRNA-episome(H4R4).
gDNA was extracted from multiple clones at different time points and revealed an accumulation of edited cells coding for H4R4 over time. Illumina-
based gDNA-seq of clone B3-3-1 to 29x coverage indicated that after 5 months ∼90% of histone H4 transcripts code for H4R4. (D) gDNA-seq-based
quantification of histone H4 copy number (for details see methods section).
multicopy genes, three features that we consider major im-
provements over currently available approaches. While use
of CRISPR–Cas9 has recently been described in T. brucei
(34), the strategy aimed to enable high-throughput analyses
and cannot be used for the three applications listed above,
instead it provides a clever strategy for the rapid deletion of
genes.
The CRISPR–Cas9-mediated approach developed in this
study allows genome editing without the need to select for
transcription of a resistance marker, a feature that opens
unique opportunities to study the effect of transcription on
chromatin structure and nuclear organization. It is becom-
ing increasingly clear that chromatin structure and nuclear
organization can affect transcription and vice versa (43).
Thus, selection for the expression of a resistance marker
gene inserted into a previously non-transcribed region of
the genome may cause changes in chromatin structure and
nuclear organization that in turn affects the expression of
surrounding genes, complicating downstream analyses. The
ability to manipulate the genome without the need to in-
sert a selectable marker can be used to delete specific non-
transcribed DNA sequence elements. Subsequently, ChIP-
seq or FISH analyses may be used to study the effect of
these deletions on chromatin structure or nuclear localiza-
tion without the confounding effect of induced transcrip-
tion of a selectable marker.
Furthermore, the precision of the outlined Cas9-
mediated genome editing approach can be exploited to edit
single nucleotides in vivo. This feature will be useful to un-
ravel the role of individual amino acids within the active
site of an enzyme or to investigate the importance of spe-
cific DNA motifs. Unusually for a eukaryote, expression of
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RNA pol II-transcribed genes is regulated predominantly
post-transcriptionally in T. brucei, at the level of RNAmat-
uration (44), RNA stability (45) and translation (46–48).
Numerous studies have identified distinct DNA sequence
motifs that can affect the different steps (49–54). Using the
episome-based CRISPR–Cas9 approach outlined here, it
is now possible to make precise mutations in the UTR or
to change the codon usage of a gene in vivo, an invaluable
tool to study regulatory motifs that may help explain the
large range in transcript-specific RNA stabilities and trans-
lational efficiencies. In addition, it will provide new options
for one of the most commonly performed genetic manipu-
lations, the addition of an epitope tag to a protein of inter-
est. In this study we have demonstrated that Cas9-mediated
genome editing can be used to insert the sequence coding
for such a tag precisely between ORF andUTR. Previously,
in situ tagging approaches developed for T. brucei involved
the replacement of the endogenous UTR with one from a
highly expressed gene, e.g. aldolase, tubulin or actin (55,56).
Inmost cases the replacement of theUTR led to an increase
in protein levels, which facilitates protein detection by im-
munofluorescence or western blotting, but is likely to result
in an unnatural protein distribution across the cell. Thus
far, the least ‘disruptive’ genome-editing approach devel-
oped for T. brucei takes advantage of the ability to remove
loxP-flanked resistancemarker cassettes by the transient ex-
pression of a CRE recombinase. While this strategy leaves
only a 34-bp loxP ‘scar’ after excision of the loxP-flanked
region (57), like all other currently available approaches, the
insertion of the loxP-flanked resistance marker requires the
selection for active transcription of the resistance marker
gene. Thus, the approach presented here is not only less dis-
ruptive to the local transcriptional landscape, it is also more
precise than other currently available approaches.
Finally, we have demonstrated that Cas9 technology can
be used to edit multicopy genes in T. brucei. The T. brucei
genome contains at least 194 gene families with ≥5 mem-
bers, representing around 20% of the∼9000 genes (58). The
most widely employed approach to study multicopy genes
is RNAi (59). While RNAi has been an extremely useful
tool to study gene functions in T. brucei, its use can be lim-
ited by incomplete transcript depletion and off-target ef-
fects. For example the high degree of sequence similarity
between the canonical histone H4 and the histone variant
H4.V makes it impossible to efficiently specifically deplete
one protein. In contrast, the CRISPR–Cas9 approach pre-
sented here can be used to edit multicopy genes without de-
tectable off-target effects.
As a proof of principle, we have replaced a specific lysine
residue of histone H4 with an arginine to mimic the con-
stitutively non-acetylated state. Histone modifications are
of great interest in T. brucei as they play important roles
in DNA repair (5,60) and transcription (3,61). However,
given that the responsible histone modifying enzymes are
often unknown or tend to have multiple target sites, it has
been difficult to unequivocally link individual histone mod-
ifications to specific biological functions. Recently we de-
veloped a quantitative proteomic-based approach to iden-
tify the target residues of histone acetyl transferases and
deacetylases (42) and an MNase-ChIP-seq protocol for the
detailed genome-wide mapping of individual histone mod-
ifications (24). In combination with these tools, the Cas9-
based approach presented here represents an invaluable col-
lection that should help unravel the role of histonemodifica-
tions in trypanosomes. A better understanding of the func-
tion of individual histonemodifications in this early branch-
ing eukaryote should shed light on the evolution of histone
modification-mediated mechanisms.
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